Gene therapy progress and prospects: the eye

Gene therapy progress and prospects: the eye

Play all audios:

Loading...

ABSTRACT The eye has unique advantages as a target organ for gene therapy of both inherited and acquired ocular disorders and offers a valuable model system for gene therapy. The eye is


readily accessible to phenotypic examination and investigation of therapeutic effects _in vivo_ by fundus imaging and electrophysiological techniques. Considerable progress has been made in


the development of gene replacement therapies for retinal degenerations resulting from gene defects in photoreceptor cells (rds, RPGRIP, RS-1) and in retinal pigment epithelial cells (MerTK,


RPE65, OA1) using recombinant adeno-associated virus and lentivirus-based vectors. Gene therapy also offers a potentially powerful approach to the treatment of complex acquired disorders


such as those involving angiogenesis, inflammation and degeneration, by the targeted sustained intraocular delivery of therapeutic proteins. Proposals for clinical trials of gene therapy for


early-onset retinal degeneration owing to defects in the gene encoding the visual cycle protein RPE65 have recently received ethical approval. Access through your institution Buy or


subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 6 print issues and online


access $259.00 per year only $43.17 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which


are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS


REVIEW OF GENE THERAPIES FOR AGE-RELATED MACULAR DEGENERATION Article 11 January 2022 CHARACTERIZATION OF A NOVEL _PDE6B_-DEFICIENT RAT MODEL OF RETINAL DEGENERATION AND TREATMENT WITH


ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY Article 29 September 2022 LATE GENE THERAPY LIMITS THE RESTORATION OF RETINAL FUNCTION IN A MOUSE MODEL OF RETINITIS PIGMENTOSA Article Open access


12 December 2023 REFERENCES * Rolling F . Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. _Gene Ther_ 2004; 11 (Suppl 1): S26–S32. Article  CAS  Google


Scholar  * Bainbridge JW, Mistry A, Schlichtenbrede FC, Smith A, Broderick C, de AM _et al_. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina. _Gene


Ther_ 2003; 10: 1336–1344. Article  CAS  Google Scholar  * Lotery AJ, Yang GS, Mullins RF, Russell SR, Schmidt M, Stone EM _et al_. Adeno-associated virus type 5: transduction efficiency and


cell-type specificity in the primate retina. _Hum Gene Ther_ 2003; 14: 1663–1671. Article  CAS  Google Scholar  * Weber M, Rabinowitz J, Provost N, Conrath H, Folliot S, Briot D _et al_.


Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal


delivery. _Mol Ther_ 2003; 7: 774–781. Article  CAS  Google Scholar  * Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J _et al_. Long-term restoration of rod and cone


vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. _Mol Ther_ 2005; 12: 1072–1082. Article  CAS  Google Scholar  * Min SH, Molday LL,


Seeliger MW, Dinculescu A, Timmers AM, Janssen A _et al_. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile


retinoschisis. _Mol Ther_ 2005; 12: 644–651. Article  CAS  Google Scholar  * Challa P, Luna C, Liton PB, Chamblin B, Wakefield J, Ramabhadran R _et al_. Lentiviral mediated gene delivery to


the anterior chamber of rodent eyes. _Mol Vis_ 2005; 11: 425–430. CAS  PubMed  PubMed Central  Google Scholar  * Loewen N, Leske DA, Cameron JD, Chen Y, Whitwam T, Simari RD _et al_.


Long-term retinal transgene expression with FIV versus adenoviral vectors. _Mol Vis_ 2004; 10: 272–280. CAS  PubMed  Google Scholar  * Cheng L, Toyoguchi M, Looney DJ, Lee J, Davidson MC,


Freeman WR . Efficient gene transfer to retinal pigment epithelium cells with long-term expression. _Retina_ 2005; 25: 193–201. Article  Google Scholar  * Tschernutter M, Schlichtenbrede FC,


Howe S, Balaggan KS, Munro PM, Bainbridge JW _et al_. Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.


_Gene Ther_ 2005; 12: 694–701. Article  CAS  Google Scholar  * Miyazaki M, Ikeda Y, Yonemitsu Y, Goto Y, Sakamoto T, Tabata T _et al_. Simian lentiviral vector-mediated retinal gene transfer


of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats. _Gene Ther_ 2003; 10: 1503–1511. Article  CAS  Google Scholar  *


Kostic C, Chiodini F, Salmon P, Wiznerowicz M, Deglon N, Hornfeld D _et al_. Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse


retina. _Gene Ther_ 2003; 10: 818–821. Article  CAS  Google Scholar  * Bainbridge JW, Stephens C, Parsley K, Demaison C, Halfyard A, Thrasher AJ _et al_. _In vivo_ gene transfer to the mouse


eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. _Gene Ther_ 2001; 8: 1665–1668. Article  CAS  Google


Scholar  * Gruter O, Kostic C, Crippa SV, Perez MT, Zografos L, Schorderet DF _et al_. Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a


physical barrier. _Gene Ther_ 2005; 12: 942–947. Article  CAS  Google Scholar  * Molina RP, Ye HQ, Brady J, Zhang J, Zimmerman H, Kaleko M _et al_. A synthetic Rev-independent bovine


immunodeficiency virus-based packaging construct. _Hum Gene Ther_ 2004; 15: 865–877. Article  CAS  Google Scholar  * Bainbridge JW, Stephens C, Parsley K, Demaison C, Halfyard A, Thrasher AJ


_et al_. _In vivo_ gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. _Gene Ther_


2001; 8: 1665–1668. Article  CAS  Google Scholar  * Poeschla EM . Non-primate lentiviral vectors. _Curr Opin Mol Ther_ 2003; 5: 529–540. CAS  PubMed  Google Scholar  * Saenz DT, Loewen N,


Peretz M, Whitwam T, Barraza R, Howell KG _et al_. Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. _J


Virol_ 2004; 78: 2906–2920. Article  CAS  Google Scholar  * Ishikawa H, Takano M, Matsumoto N, Sawada H, Ide C, Mimura O _et al_. Effect of GDNF gene transfer into axotomized retinal


ganglion cells using _in vivo_ electroporation with a contact lens-type electrode. _Gene Ther_ 2005; 12: 289–298. Article  CAS  Google Scholar  * Matsuda T, Cepko CL . Electroporation and


RNA interference in the rodent retina _in vivo_ and _in vitro_. _Proc Natl Acad Sci U S A_ 2004; 101: 16–22. Article  CAS  Google Scholar  * Chalberg TW, Genise HL, Vollrath D, Calos MP .


phiC31 integrase confers genomic integration and long-term transgene expression in rat retina. _Invest Ophthalmol Vis Sci_ 2005; 46: 2140–2146. Article  Google Scholar  * Folliot S, Briot D,


Conrath H, Provost N, Cherel Y, Moullier P _et al_. Sustained tetracycline-regulated transgene expression _in vivo_ in rat retinal ganglion cells using a single type 2 adeno-associated


viral vector. _J Gene Med_ 2003; 5: 493–501. Article  CAS  Google Scholar  * Lebherz C, Auricchio A, Maguire AM, Rivera VM, Tang W, Grant RL _et al_. Long-term inducible gene expression in


the eye via adeno-associated virus gene transfer in nonhuman primates. _Hum Gene Ther_ 2005; 16: 178–186. Article  CAS  Google Scholar  * Smith JR, Verwaerde C, Rolling F, Naud MC, Delanoye


A, Thillaye-Goldenberg B _et al_. Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. _Hum Gene


Ther_ 2005; 16: 1037–1046. Article  CAS  Google Scholar  * Bainbridge JW, Mistry A, Binley K, de AM, Thrasher AJ, Naylor S _et al_. Hypoxia-regulated transgene expression in experimental


retinal and choroidal neovascularization. _Gene Ther_ 2003; 10: 1049–1054. Article  CAS  Google Scholar  * Schlichtenbrede FC, da CL, Stephens C, Smith AJ, Georgiadis A, Thrasher AJ _et al_.


Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. _J Gene Med_ 2003; 5: 757–764. Article  CAS  Google Scholar  * Pawlyk BS,


Smith AJ, Buch PK, Adamian M, Hong DH, Sandberg MA _et al_. Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP.


_Invest Ophthalmol Vis Sci_ 2005; 46: 3039–3045. Article  Google Scholar  * Zeng Y, Takada Y, Kjellstrom S, Hiriyanna K, Tanikawa A, Wawrousek E _et al_. RS-1 Gene Delivery to an Adult Rs1h


Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis. _Invest Ophthalmol Vis Sci_ 2004; 45: 3279–3285. Article  Google Scholar  *


Smith AJ, Schlichtenbrede FC, Tschernutter M, Bainbridge JW, Thrasher AJ, Ali RR . AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. _Mol


Ther_ 2003; 8: 188–195. Article  CAS  Google Scholar  * Surace EM, Domenici L, Cortese K, Cotugno G, Di VU, Venturi C _et al_. Amelioration of both functional and morphological abnormalities


in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer. _Mol Ther_ 2005; 12: 652–658. Article  CAS  Google Scholar  * Dejneka NS, Surace EM, Aleman TS,


Cideciyan AV, Lyubarsky A, Savchenko A _et al_. _In utero_ gene therapy rescues vision in a murine model of congenital blindness. _Mol Ther_ 2004; 9: 182–188. Article  CAS  Google Scholar  *


Narfstrom K, Katz ML, Ford M, Redmond TM, Rakoczy E, Bragadottir R . _In vivo_ gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement. _J Hered_ 2003; 94:


31–37. Article  CAS  Google Scholar  * Narfstrom K, Katz ML, Bragadottir R, Seeliger M, Boulanger A, Redmond TM _et al_. Functional and structural recovery of the retina after gene therapy


in the RPE65 null mutation dog. _Invest Ophthalmol Vis Sci_ 2003; 44: 1663–1672. Article  Google Scholar  * Hennig AK, Ogilvie JM, Ohlemiller KK, Timmers AM, Hauswirth WW, Sands MS .


AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice. _Mol Ther_ 2004; 10: 106–116.


Article  CAS  Google Scholar  * Gorbatyuk MS, Pang JJ, Thomas Jr J, Hauswirth WW, Lewin AS . Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA


replacement approach. _Mol Vis_ 2005; 11: 648–656. CAS  PubMed  Google Scholar  * Lingor P, Koeberle P, Kugler S, Bahr M . Down-regulation of apoptosis mediators by RNAi inhibits


axotomy-induced retinal ganglion cell death _in vivo_. _Brain_ 2005; 128: 550–558. Article  Google Scholar  * Buch PK, MacLaren RE, Duran Y, Balaggan KS, MacNeil A, Schlichtenbrede FC _et


al_. In contrast to AAV-mediated CNTF expression, AAV-mediated GDNF expression ehnances gene replacement therapy in rodent models of retinal degeneration. _Mol Ther_ (in press). *


Schlichtenbrede FC, MacNeil A, Bainbridge JW, Tschernutter M, Thrasher AJ, Smith AJ _et al_. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal


function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. _Gene Ther_ 2003; 10: 523–527. Article  CAS  Google Scholar  * Rota R, Riccioni T, Zaccarini M, Lamartina S,


Gallo AD, Fusco A _et al_. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. _J Gene Med_ 2004; 6: 992–1002. Article  CAS  Google Scholar  *


Rakoczy PE, Brankov M, Fonceca A, Zaknich T, Rae BC, Lai CM . Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a


potential model for diabetic retinopathy. _Diabetes_ 2003; 52: 857–863. Article  CAS  Google Scholar  * Deng WT, Yan Z, Dinculescu A, Pang J, Teusner JT, Cortez NG _et al_. Adeno-associated


virus-mediated expression of vascular endothelial growth factor peptides inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. _Hum Gene Ther_ 2005; 16:


1247–1254. Article  CAS  Google Scholar  * Lai CC, Wu WC, Chen SL, Sun MH, Xiao X, Ma L _et al_. Recombinant adeno-associated virus vector expressing angiostatin inhibits preretinal


neovascularization in adult rats. _Ophthalmic Res_ 2005; 37: 50–56. Article  CAS  Google Scholar  * Gehlbach P, Demetriades AM, Yamamoto S, Deering T, Duh EJ, Yang HS _et al_. Periocular


injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. _Gene Ther_ 2003; 10: 637–646. Article  CAS  Google Scholar  * Saishin Y,


Silva RL, Saishin Y, Kachi S, Aslam S, Gong YY _et al_. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. _Hum Gene


Ther_ 2005; 16: 473–478. Article  CAS  Google Scholar  * Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM _et al_. Small interfering RNA (siRNA) targeting VEGF effectively inhibits


ocular neovascularization in a mouse model. _Mol Vis_ 2003; 9: 210–216. CAS  Google Scholar  * Campochiaro PA . Ocular neovascularisation and excessive vascular permeability. _Expert Opin


Biol Ther_ 2004; 4: 1395–1402. Article  CAS  Google Scholar  * Verwaerde C, Naud MC, Delanoye A, Wood M, Thillaye-Goldenberg B, Auriault C _et al_. Ocular transfer of retinal glial cells


transduced _ex vivo_ with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis. _Gene Ther_ 2003; 10: 1970–1981. Article  CAS  Google Scholar  *


Broderick CA, Smith AJ, Balaggan KS, Georgiadis A, Buch PK, Trittibach PC _et al_. Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and


subsequent photoreceptor damage during experimental autoimmune uveitis. _Mol Ther_ 2005; 12: 369–373. Article  CAS  Google Scholar  * van Adel BA, Kostic C, Deglon N, Ball AK, Arsenijevic Y


. Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time. _Hum Gene Ther_ 2003; 14: 103–115.


Article  CAS  Google Scholar  * Martin KR, Quigley HA, Zack DJ, Levkovitch-Verbin H, Kielczewski J, Valenta D _et al_. Gene therapy with brain-derived neurotrophic factor as a protection:


retinal ganglion cells in a rat glaucoma model. _Invest Ophthalmol Vis Sci_ 2003; 44: 4357–4365. Article  Google Scholar  * Zhou Y, Pernet V, Hauswirth WW, Di PA . Activation of the


extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. _Mol Ther_ 2005; 12: 402–412. Article  CAS  Google Scholar  * Carlson EC,


Liu CY, Yang X, Gregory M, Ksander B, Drazba J _et al_. _In vivo_ gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter.


_Invest Ophthalmol Vis Sci_ 2004; 45: 2194–2200. Article  Google Scholar  Download references ACKNOWLEDGEMENTS James Bainbridge is a Wellcome Advanced Fellow (Grant 074617/Z/04/Z); Mei Hong


Tan is supported by the UK Department of Health. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Division of Molecular Therapy, Institute of Ophthalmology, University College London, London,


UK J W B Bainbridge, M H Tan & R R Ali Authors * J W B Bainbridge View author publications You can also search for this author inPubMed Google Scholar * M H Tan View author publications


You can also search for this author inPubMed Google Scholar * R R Ali View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence


to R R Ali. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Bainbridge, J., Tan, M. & Ali, R. Gene therapy progress and prospects: the eye. _Gene


Ther_ 13, 1191–1197 (2006). https://doi.org/10.1038/sj.gt.3302812 Download citation * Received: 03 January 2006 * Revised: 05 May 2006 * Accepted: 19 May 2006 * Published: 13 July 2006 *


Issue Date: 01 August 2006 * DOI: https://doi.org/10.1038/sj.gt.3302812 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link


Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * adeno-associated virus *


lentivirus * retina * RPE65